Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Rybrevant
Generic name : Amivantamab
Manufactured By : Ortho Biotech
Indications : mNSCLC EGFR exon 20 insertion mutations
Medicine Description : Rybrevant is a bispecific EGFR-MET antibody for EGFR exon 20 insertion-mutant NSCLC. It blocks EGFR and MET pathways, inhibiting tumor growth. Given via IV infusion, it improves progression-free survival. Side effects include infusion reactions, skin rash, swelling, and lung inflammation. Skin and lung function monitoring are essential.
Rybrevant (Amivantamab) is a prescription medication used to treat non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations, specifically in patients who have progressed on or after prior treatment with chemotherapy.
Rybrevant is a monoclonal antibody that targets and blocks the epidermal growth factor receptor (EGFR) and MET receptor, which are involved in the growth and spread of cancer cells. By inhibiting these pathways, Rybrevant helps to slow the growth of the cancer.
Rybrevant is prescribed to adults with metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations who have already received previous treatment with chemotherapy.
Rybrevant is administered through an intravenous (IV) infusion by a healthcare provider, typically every week for the first two months, followed by once every two weeks thereafter.
Common side effects of Rybrevant include rash, diarrhea, fatigue, nausea, fever, and upper respiratory tract infections.
Yes, Rybrevant can cause serious side effects such as lung problems (e.g., interstitial lung disease), severe infusion reactions, and liver damage. Contact your doctor if you experience severe symptoms.
Rybrevant is generally taken as long as it is effective in treating the cancer and is well-tolerated, or until your doctor advises stopping treatment.
It is advisable to avoid alcohol while taking Rybrevant as it may exacerbate side effects like dizziness, fatigue, and liver issues.
No, Rybrevant may harm an unborn baby. Women should use effective contraception and avoid becoming pregnant during treatment with Rybrevant.
Yes, Rybrevant may interact with other medications, including immunosuppressants and certain cancer treatments. Inform your doctor about all medications you are taking.
If you miss a dose of Rybrevant, contact your healthcare provider to reschedule the infusion as soon as possible. Do not double up on doses.
Since Rybrevant is given through an intravenous infusion, it is not affected by food intake.
It is important to monitor for lung problems, skin reactions, and liver function while using Rybrevant. You should also avoid pregnancy during treatment.
Rybrevant should be stored in a healthcare facility under refrigeration until administered. It should not be frozen.
Rybrevant is available by prescription and can be administered at a healthcare facility or infusion center. Your doctor will guide you on how to access this treatment. Pharma Five assists in its procurement.